Fulcrum Therapeutics(FULC) - 2025 Q2 - Quarterly Results
2025-07-29 20:34
Exhibit 99.1 Fulcrum Therapeutics Announces Recent Business Highlights and Financial Results for Second Quarter 2025 ― Announced results from the 12 mg dose cohort (n=16) of the Phase 1b PIONEER trial of pociredir in sickle cell disease (SCD); pociredir was generally well-tolerated with no treatment-related serious adverse events (SAEs) ― ― Observed robust and rapid pan-cellular increases in fetal hemoglobin (HbF); meaningful improvements in key markers of hemolysis and anemia; encouraging trends in vaso-oc ...
Graphic Packaging(GPK) - 2025 Q2 - Quarterly Results
2025-07-29 20:33
Operating Results Net Sales Second quarter 2025 Net Sales decreased 1% to $2,204 million, versus $2,237 million in the same quarter last year. The $33 million decline was driven by a $40 million impact from the divestiture of the Augusta, GA bleached paperboard manufacturing facility and reduced open market sales participation, partially offset by a $20 million favorable foreign exchange impact, while modest price pressure was partially offset by a modest volume increase. Net Income in second quarter 2025 w ...
GATX(GATX) - 2025 Q2 - Quarterly Results
2025-07-29 20:31
Exhibit 99.1 NEWS RELEASE FOR IMMEDIATE RELEASE GATX CORPORATION REPORTS 2025 SECOND-QUARTER RESULTS CHICAGO, July 29, 2025—GATX Corporation (NYSE: GATX) today reported 2025 second-quarter net income of $75.5 million, or $2.06 per diluted share, compared to net income of $44.4 million, or $1.21 per diluted share, in the second quarter of 2024. The 2024 second-quarter results include a net negative impact of $8.0 million, or $0.22 per diluted share, from Tax Adjustments and Other Items. Net income for the fi ...
Chart(GTLS) - 2025 Q2 - Quarterly Results
2025-07-29 20:23
Second quarter 2025 highlights compared to second quarter 2024: "We booked $1.50 billion of orders in the second quarter 2025 demonstrating continued strength in our end markets, more systems and solutions sales, and an increasing aftermarket, service and repair attachment with customers increasingly utilizing our process technologies," stated Jill Evanko, Chart Industries' CEO and President. "Our sales in solutions and aftermarket and our team's continuous improvement efforts contributed to our adjusted op ...
GeneDx (WGS) - 2025 Q2 - Quarterly Report
2025-07-29 20:18
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2025 Commission file number 001-39482 GeneDx Holdings Corp. 333 Ludlow Street, North Tower; 6th Floor Stamford, Connecticut 06902 (Address of Principal Executive Offices) (Zip Code) Registrant's telephone number, including area code: (888) 729-1206 Securities registered pursuant to Section 12(b) of ...
NexPoint Residential Trust(NXRT) - 2025 Q2 - Quarterly Results
2025-07-29 20:16
Exhibit 99.1 29 July 2025 | NYSE: NXRT EARNINGS SUPPLEMENT: SECOND QUARTER 2025 NEXPOINT RESIDENTIAL TRUST, INC. 300 CRESCENT COURT, SUITE 700 DALLAS, TX 75201 INVESTOR RELATIONS: KRISTEN GRIFFITH NXRT.NEXPOINT.COM NEXPOINT RESIDENTIAL TRUST, INC. [NYSE:NXRT] TABLE OF CONTENTS | Earnings Release | 1 | | --- | --- | | Cautionary Statement Regarding Forward-Looking | 3 | | Statements | | | Overview | 4 | | Highlights of Recent Activity | 5 | | Financial Summary | 7 | | 2025 Full Year Guidance | 8 | | Componen ...
Norfolk Southern(NSC) - 2025 Q2 - Quarterly Report
2025-07-29 20:15
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2025 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ___________ to___________ Commission File Number: 1-8339 NORFOLK SOUTHERN CORPORATION (Exact name of registrant as specified in its charter) Virginia 52-1188014 (State or ot ...
Ecolab(ECL) - 2025 Q2 - Quarterly Results
2025-07-29 20:11
Exhibit 99.1 News Release Investor Contact: Media Contact: Andrew Hedberg (651) 250-2185 Nigel Glennie (651) 250-2576 Andrew Pearson (651) 250-3654 ECOLAB DELIVERS ANOTHER STRONG QUARTER OF DOUBLE-DIGIT EPS GROWTH REPORTED DILUTED EPS $1.84; ADJUSTED DILUTED EPS $1.89, +13% MAINTAINS 2025 ADJUSTED DILUTED EPS OUTLOOK: $7.42 - $7.62, +12% - 15% SECOND QUARTER HIGHLIGHTS OUTLOOK | | | | Second Quarter Ended June 30 | | | | | --- | --- | --- | --- | --- | --- | --- | | | Reported | | | Adjusted | | | | (unaudi ...
Norfolk Southern(NSC) - 2025 Q2 - Quarterly Results
2025-07-29 20:10
Exhibit 99.2 Norfolk Southern Corporation and Subsidiaries Consolidated Statements of Income (Unaudited) | | First Six Months | | | --- | --- | --- | | | 2025 ($ in millions) | 2024 | | Cash flows from operating activities | | | | Net income | $ 1,518 | $ 790 | | Reconciliation of net income to net cash provided by operating activities: | | | | Depreciation | 692 | 672 | | Deferred income taxes | 109 | 5 | | Gains and losses on properties | (57) | (25) | | Changes in assets and liabilities affecting operati ...
Camden National (CAC) - 2025 Q2 - Quarterly Results
2025-07-29 20:05
"We're pleased to report strong results in our first full quarter as a unified organization following the Northway Financial acquisition," said Simon Griffiths, President and Chief Executive Officer of Camden National. "During the quarter, we began to unlock the financial potential of the combined franchise, with pre-tax, pre-provision income— excluding one-time merger-related expenses—increasing 13% over the prior quarter. This performance reflects achievement of cost synergies and solid revenue growth, re ...